Location History:
- Wolschwiller, FR (2010)
- Basel, CH (2012)
Company Filing History:
Years Active: 2010-2012
Title: Marie Claude Bernhard: Innovator in Pharmaceutical Chemistry
Introduction
Marie Claude Bernhard is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic potential. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
Bernhard's latest patents include the development of 2,4-Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors. These patents disclose pyrimidine derivatives of a specific formula, wherein R, R, R, R, and Z have particular significations as indicated in the claims. These compounds exhibit interesting pharmaceutical properties, making them valuable in the treatment of various diseases.
Career Highlights
Throughout her career, Bernhard has been associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative research and development in the pharmaceutical sector. Her contributions have played a crucial role in advancing therapeutic options for patients.
Collaborations
Marie Claude Bernhard has collaborated with notable colleagues, including Rolf Baenteli and Peter Buehlmayer. These collaborations have fostered a productive research environment, leading to the successful development of new pharmaceutical compounds.
Conclusion
Marie Claude Bernhard is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific research.